TrialBMC cancer2016

Five-year disease-free survival among stage II-IV breast cancer patients receiving FAC and AC chemotherapy in phase II clinical trials of Panagen.

Anastasia S Proskurina et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.